Penumbra Inc (PEN) USD0.001
Sell:$262.11Buy:$262.12
$3.30
(1.25%)
- This stock can be held in a
Stocks and Shares ISA$3.30
(1.25%)$3.30
(1.25%)Company Information
About this company
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Key people
Key facts
- EPIC-
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS70975L1070
- Market cap$10.17bn
- Employees4,200
- Shares in issue38.38m
- ExchangeNew York Stock Exchange
- IndexS&P 400 Mid Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.